CLINICAL_TRIALS
withdrawal
· 2024-09-25
Clinical Trial Update: Clinical Performance Evaluation of the C2i Test
Summary
The clinical trial NCT05860543 evaluating the C2i Test for muscle-invasive bladder cancer has been withdrawn.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: University of Texas Southwestern Medical Center | Conditions: Muscle Invasive Bladder Cancer | Status: WITHDRAWN